Sanofi, Flatiron Health in pact to redesign oncology clinical trials

BIOMARKER

Gray Frame Corner
Gray Frame Corner

1. Sanofi and Flatiron Health have partnered to enhance clinical trials for cancer treatments by improving data transfers.

Gray Frame Corner
Gray Frame Corner

2. The partnership aims to improve clinical trial data acquisition, delivery, and quality.

Gray Frame Corner
Gray Frame Corner

3. The data will be transferred from the electronic health record (EHR) directly into the electronic data capture (EDC) system.

Gray Frame Corner
Gray Frame Corner

4. The system used for this transfer is Flatiron Health’s EHR-to-EDC product, Flatiron Clinical Pipe.

Gray Frame Corner
Gray Frame Corner

5. The financial terms of the agreement were not disclosed.

Gray Frame Corner
Gray Frame Corner

6. The partnership seeks to reduce time spent on manual, high-volume data entry and downstream data resolution issues.

Gray Frame Corner
Gray Frame Corner

7. This will allow physicians and clinicians more time to spend with patients.

Gray Frame Corner
Gray Frame Corner

8. Sanofi and Flatiron will set data standards and mapping to increase the volume and types of data eligible for automated transfer.

Gray Frame Corner
Gray Frame Corner

9. The use of the Flatiron Clinical program could potentially halve the number of queries, leading to increased efficiencies.

Gray Frame Corner
Gray Frame Corner

10. In January 2022, Flatiron expanded its services globally through a partnership with Japan’s National Cancer Center Hospital East.

Gray Frame Corner
Gray Frame Corner

Swipe up for more BIOMARKER news!